- Home
- OGI vs IPSC Comparison
OGI vs IPSC Comparison
Compare OGI & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGI
- IPSC
- Stock Information
- Founded
- OGI 2013
- IPSC 2019
- Country
- OGI Canada
- IPSC United States
- Employees
- OGI N/A
- IPSC N/A
- Industry
- OGI Biotechnology: Pharmaceutical Preparations
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- OGI Health Care
- IPSC Health Care
- Exchange
- OGI Nasdaq
- IPSC Nasdaq
- Market Cap
- OGI 176.7M
- IPSC 49.6M
- IPO Year
- OGI N/A
- IPSC 2021
- Fundamental
- Price
- OGI $1.32
- IPSC $0.56
- Analyst Decision
- OGI
- IPSC Strong Buy
- Analyst Count
- OGI 0
- IPSC 5
- Target Price
- OGI N/A
- IPSC $3.33
- AVG Volume (30 Days)
- OGI 556.9K
- IPSC 1.2M
- Earning Date
- OGI 08-12-2025
- IPSC 08-07-2025
- Dividend Yield
- OGI N/A
- IPSC N/A
- EPS Growth
- OGI N/A
- IPSC N/A
- EPS
- OGI 0.10
- IPSC N/A
- Revenue
- OGI $135,031,829.00
- IPSC $114,898,000.00
- Revenue This Year
- OGI $50.30
- IPSC $1,064.82
- Revenue Next Year
- OGI $16.01
- IPSC N/A
- P/E Ratio
- OGI $13.00
- IPSC N/A
- Revenue Growth
- OGI 20.49
- IPSC 8286.72
- 52 Week Low
- OGI $0.85
- IPSC $0.34
- 52 Week High
- OGI $2.08
- IPSC $3.29
- Technical
- Relative Strength Index (RSI)
- OGI 48.55
- IPSC 46.47
- Support Level
- OGI $1.25
- IPSC $0.52
- Resistance Level
- OGI $1.37
- IPSC $0.60
- Average True Range (ATR)
- OGI 0.06
- IPSC 0.04
- MACD
- OGI -0.01
- IPSC -0.01
- Stochastic Oscillator
- OGI 27.45
- IPSC 25.19
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.